AzTrials
AzTrials

MyopiaWEARNCT01704729

The Children's WEAR Trial(Phase 1&2)

A study testing group1, group2 and group3 in people with Myopia, run by Sun Yat-sen University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Phase I: Focus groups on different designs of adjustable glasses and standard glasses (August-September 2012) Phase II: Two-month randomized trial comparing four groups: (September 2012 - August 2013) Read more about this study

Who is it for?
Ages 12 to 17 years
Conditions the study is for
Myopia
What is being tested?
group1, group2 and group3
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,300 participants
Where
1 siteChina
Study dates
Sep 2012to 1 Apr 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • phase1: - aged 12-17 years
  • with <= -1.00D of myopic refractive error in each eye phase2: - 12-15 years old children from two locations in Guangdong Province
  • with uncorrected vision </= 6/12 in at least one eye thought to be due to refractive error (that is, correctable to at least 6/7.5 with cycloplegic subjective refraction by an optometrist)

Who cannot join

  • those corrected VA can not up to 6/7.5 with cycloplegic subjective refraction by an optometrist
  • those with significant strabismus or vision abnormality (keratopathy, cataract, vitreous macular diseases ), or with vision deficiency ( amblyopia ) children are to be excluded.
  • Children developing acquired vision problems other than myopia

Trial locations and contacts

1 site in 1 country.

China1 site
  • Zhongshan Ophthalmic Center

    Guangzhou, Guangdong, 510060

Other trials in China

About this study

Official title: The Children's WEAR (Wearability and Evaluation of Adjustable Refraction) Trial(Phase 1&2)

Phase I: Focus groups on different designs of adjustable glasses and standard glasses (August-September 2012) Phase II: Two-month randomized trial comparing four groups: (September 2012 - August 2013)

Read the detailed description

Phase I: Focus groups on different designs of adjustable glasses and standard glasses (August-September 2012) Phase II: Two-month randomized trial comparing four groups: self-refraction with adjustable glasses, receiving custom standard glasses; subjective refraction by an expert refractionist after cycloplegic automated refraction and receiving custom standard glasses; subjective refraction by a rural refractionist after cycloplegic automated refraction, receiving custom standard glasses; and subjective refraction by an expert refractionist after cycloplegic automated refraction receiving ready made glasses (September 2012 - August 2013)

Conditions
Myopia
Being tested
group1, group2, group3, group4
Keywords
Myopia, Focus groups, refraction, Glasses, spectacles
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • group1Procedure or surgery

    Non-cycloplegic self-refraction +conventional glasses

  • group2Procedure or surgery

    Cycloplegic subjective refraction by experienced optometrist +conventional glasses

  • group3Procedure or surgery

    Cycloplegic subjective refraction by Rural Refractionist Program + conventional glasses

  • group4Procedure or surgery

    Cycloplegic subjective refraction by an experienced optometrist +ready-made glasses

Study groups in NCT01704729
Study groupRoleWhat they receive
group2OtherCycloplegic subjective refraction by an experienced optometrist or ophthalmologist
Receives: Procedure: group2
group3OtherCycloplegic subjective refraction by a "vision technician" trained in the Zhongshan Ophthalmic Center's Rural Refractionist Program
Receives: Procedure: group3
group4OtherCycloplegic subjective refraction by an experienced optometrist or ophthalmologist
Receives: Procedure: group4
group1OtherNon-cycloplegic self-refraction using First Generation, Child-Specific fluid-filled adjustable spectacles and updated self-refraction protocol
Receives: Procedure: group1

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual acuity with and without study refractive correction

    Measured: 2 months

Secondary outcomes (4)
  1. Self-reported and Supplemental visual functioning

    Measured: 2 months

  2. frequency of glasses-wear and the reason why the frequency is low

    Measured: 2 months

  3. Accuracy of spectacles given to children

    Measured: 2 months

  4. Value attached to the glasses and satisfaction to the glasses

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Oct 2012 (estimated)
  2. Study startSep 2012
  3. Primary completion1 Apr 2016
  4. Study completion1 Apr 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01704729
Sponsor's protocol ID
ZOC-WEAR-1
Acronym
WEAR
Status last verified
Mar 2021
First submitted
20 Sep 2012
Last updated
23 Mar 2021
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing group1, group2 and group3 in people with Myopia, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual acuity with and without study refractive correction (time frame: 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2021; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in